Explore how DFMEA transforms product development by identifying potential risks, optimizing designs, and ensuring compliance with regulatory standards.

Forget the drug discovery hype. Here’s how the world’s largest pharma company is seeing a payoff from AI right now.

♦ UPDATE: Learn about companies that are applying this timeless advice today. A version of this article appeared in the July–August 2008 issue of Harvard Business Review. James L. Heskett is a Baker ...

Jason Fernando is a professional investor and writer who enjoys tackling and communicating complex business and financial problems. Natalya Yashina is a CPA, DASM with over 12 years of experience in ...